Kevin Harrington, Professor in Biological Cancer Therapies at Institute of Cancer Research, shared a post on LinkedIn:
“Having just returned from ESMO, it is a good opportunity to reflect on some important events over the last few days.
On Friday 17th October, I had the pleasure of co-chairing a session with Prof Irene Brana on Refining Strategies to Boost Immunotherapeutic Effectiveness in Head and Neck Cancer.
The session included superb presentations from Prof Inge Tinhofer-Keilholz (on organoid models for H&N cancer research) and Prof Makoto Tahara (on the rationale for combination therapies). I was able to present thoughts on the role of DNA repair inhibition, cell death modulation and innate immune activation via the STING pathway.
It was a very interactive and instructive session with lots of excellent take home messages for attendees. I hope it will also be viewed on the ESMO platform by those unable to attend.”
More posts from ESMO25.